Page last updated: 2024-10-28

ibudilast and Amyloid Deposits

ibudilast has been researched along with Amyloid Deposits in 1 studies

Research Excerpts

ExcerptRelevanceReference
"Ibudilast is a multi-target drug, as it is a phosphodiesterase inhibitor and toll-like receptor 4 (TLR4) antagonist."5.91Repurposing ibudilast to mitigate Alzheimer's disease by targeting inflammation. ( Chaudry, O; Figueiredo-Pereira, ME; Liu, Q; Oliveros, G; Qiu, Y; Rockwell, P; Serrano, PA; Wallace, CH; Xie, L, 2023)
"Ibudilast is a multi-target drug, as it is a phosphodiesterase inhibitor and toll-like receptor 4 (TLR4) antagonist."1.91Repurposing ibudilast to mitigate Alzheimer's disease by targeting inflammation. ( Chaudry, O; Figueiredo-Pereira, ME; Liu, Q; Oliveros, G; Qiu, Y; Rockwell, P; Serrano, PA; Wallace, CH; Xie, L, 2023)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's1 (100.00)2.80

Authors

AuthorsStudies
Oliveros, G1
Wallace, CH1
Chaudry, O1
Liu, Q1
Qiu, Y1
Xie, L1
Rockwell, P1
Figueiredo-Pereira, ME1
Serrano, PA1

Other Studies

1 other study available for ibudilast and Amyloid Deposits

ArticleYear
Repurposing ibudilast to mitigate Alzheimer's disease by targeting inflammation.
    Brain : a journal of neurology, 2023, 03-01, Volume: 146, Issue:3

    Topics: Alzheimer Disease; Amyloid beta-Peptides; Animals; Disease Models, Animal; Drug Repositioning; Femal

2023